These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19863266)

  • 1. Psychotic depression: a peculiar presentation for multiple sclerosis.
    Agan K; Gunal DI; Afsar N; Tuncer N; Kuscu K
    Int J Neurosci; 2009; 119(11):2124-30. PubMed ID: 19863266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses.
    Beck RW; Chandler DL; Cole SR; Simon JH; Jacobs LD; Kinkel RP; Selhorst JB; Rose JW; Cooper JA; Rice G; Murray TJ; Sandrock AW
    Ann Neurol; 2002 Apr; 51(4):481-90. PubMed ID: 11921054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk of affective disorder in multiple sclerosis].
    Stenager EN; Stage KB; Stenager E
    Ugeskr Laeger; 2011 Jan; 173(2):123-6. PubMed ID: 21219844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple sclerosis and major depression resistant to treatment. Case of a patient with antidepressive therapy-induced mood disorder, associated with manic features].
    Pariante CM; Orrù MG; Carpiniello B; Rudas N
    Clin Ter; 1995; 146(6-7):449-52. PubMed ID: 7586996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.
    Bagert B; Camplair P; Bourdette D
    CNS Drugs; 2002; 16(7):445-55. PubMed ID: 12056920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? Yes].
    Debouverie M
    Rev Neurol (Paris); 2015 Sep; 171(8-9):605-6. PubMed ID: 26337481
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluvoxamine treatment of major depression associated with multiple sclerosis.
    Benedetti F; Campori E; Colombo C; Smeraldi E
    J Neuropsychiatry Clin Neurosci; 2004; 16(3):364-6. PubMed ID: 15377746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin and interferon: successful treatment of optic neuritis in pediatric multiple sclerosis.
    Spalice A; Properzi E; Lo Faro V; Acampora B; Iannetti P
    J Child Neurol; 2004 Aug; 19(8):623-6. PubMed ID: 15605474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute demyelinating optic neuritis.
    Foroozan R; Buono LM; Savino PJ; Sergott RC
    Curr Opin Ophthalmol; 2002 Dec; 13(6):375-80. PubMed ID: 12441840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with beta-interferon should be started already after the first attack of MS].
    Söderström M
    Lakartidningen; 2001 Feb; 98(6):587-90, 593-4. PubMed ID: 11475246
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and management of multiple sclerosis: case studies.
    Woo DA; Olek MJ; Frohman EM
    Neurol Clin; 2006 May; 24(2):199-214. PubMed ID: 16684629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial.
    Patten SB; Metz LM
    Mult Scler; 2001 Aug; 7(4):243-8. PubMed ID: 11548984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute delirium, delusion, and depression during IFN-beta-1a therapy for multiple sclerosis: a case report.
    Goëb JL; Cailleau A; Lainé P; Etcharry-Bouyx F; Maugin D; Duverger P; Gohier B; Rannou-Dubas K; Dubas F; Garré JB
    Clin Neuropharmacol; 2003; 26(1):5-7. PubMed ID: 12567157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
    De Stefano N; Comi G; Kappos L; Freedman MS; Polman CH; Uitdehaag BM; Hennessy B; Casset-Semanaz F; Lehr L; Stubinski B; Jack DL; Barkhof F
    J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):647-53. PubMed ID: 24292999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice. Optic neuritis.
    Balcer LJ
    N Engl J Med; 2006 Mar; 354(12):1273-80. PubMed ID: 16554529
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of optic neuritis.
    Menon V; Saxena R; Misra R; Phuljhele S
    Indian J Ophthalmol; 2011; 59(2):117-22. PubMed ID: 21350281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis.
    CHAMPS Study Group
    Am J Ophthalmol; 2001 Oct; 132(4):463-71. PubMed ID: 11589865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiologically isolated syndrome: a clinical and therapeutic dilemma].
    García-Estévez DA
    Rev Neurol; 2012 Jul; 55(1):61-2. PubMed ID: 22718410
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosis.
    Cross AH; Wu GF
    Nat Rev Neurol; 2010 Nov; 6(11):588-9. PubMed ID: 21048798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.